PN 79062
RN 01042 
AN 79126800
AU Hoogkamp-Korstanje-J-A.  Westerdaal-N-A.
TI In vitro susceptibility of pseudomonas to four
   beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin,
   piperacillin), to four aminoglycosides (kanamycin, amikacin,
   gentamicin, tobramycin) and to colimycin.
SO Chemotherapy. 1979. 25(1). P 48-53.
MJ AMINOGLYCOSIDES: pd.  CEPHALOTHIN: pd.  COLISTIN: pd.
   PENICILLINS: pd.  PSEUDOMONAS: de.
MN AMIKACIN: pd.  AMPICILLIN: pd.  CARBENICILLIN: pd.  CHILD.
   COMPARATIVE-STUDY.  CYSTIC-FIBROSIS: mi.  DRUG-RESISTANCE-MICROBIAL.
   GENTAMICINS: pd.  HUMAN.  KANAMYCIN: pd.
   MICROBIAL-SENSITIVITY-TESTS.  SPUTUM: mi.  TOBRAMYCIN: pd.
AB Of 97 well-defined strains of Pseudomonas, isolated from sputum of
   patients with cystic fibrosis (CF), the minimum inhibitory
   concentration (MIC) of several antibiotics was determined with a
   broth dilution method. The majority of the strains were resistant to
   ampicillin and cephalothin, moderately susceptible to carbenicillin
   (70% to 100 microgram/ml) and highly susceptible to piperacillin
   (100% to 25 microgram/ml, 88% to 6.25 microgram and 60% to 3.12
   microgram/ml). If the pharmacological properties of piperacillin are
   comparable with those of carbenicillin, it can be expected that the
   sputum level of this drug will be adequate to treat Pseudomonas
   pulmonary infections. At the lowest concentration tested (0.78
   microgram/ml) 3% of the strains were susceptible to kanamycin, 85,5%
   to amikacin, 95% to gentamicin, 98% of tobramycin, and 80% to
   colimycin. With regard to clinically attainable concentrations, 98.9%
   of the strains were susceptible to gentamicin and tobramycin 97.9% to
   amikacin, 96.9% to colimycin, 88.6%  to piperacillin, 38% to
   carbenicillin, 25.7% to kanamycin, 12.3% to ampicillin, and 1% to
   cephalothin.
RF 001   BLAIR JE              MANUAL OF CLINICAL MICROBIOLO            970
   002   BOXERBAUM B           J INFECT DIS SUPPL             122    59 970
   003   BOXERBAUM B           J INFECT DIS SUPPL             124   293 971
   004   COWAN ST              MANUAL FOR THE IDENTIFICATION            973
   005   ERICSSON HM           ACTA PATH MICROBIOL SCAND     S217       971
   006   MARKS MI              J PEDIATR                       79   822 971
   007   MONROE PW             APPL MICROBIOL                  18   214 969
   008   PENNINGTON JE         ANTIMICROB AGENTS CHEMOTHER      4   299 973
   009   PHAIR JP              AM J DIS CHILD                 120    22 970
   010   REYNOLDS AV           BR MED J                         3   778 974
   011   SAGGERS BA            ARCH DIS CHILD                  43   404 968
   012   WOOD RE               PSEUDOMONAS INFECTION IN CF P            975
   013   ZIERDT CH             J CLIN MICROBIOL                 1   521 975
CT   1   HOOGKAMPKORSTANJE JAA J ANTIMICROB CHEMOTHER           8   101 981
     2   HOOGKAMPKORSTANJE JAA INFECTION                       10  S257 982
     3   HOOGKAMPKORSTANJE JAA J ANTIMICROB CHEMOTHER          12   175 983
     4   SEGNI G               CURR THER RES CLIN EXP          33   265 983